Genentech and Roche Present New Insights in Alzheimer’s Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAIC
SOUTH SAN FRANCISCO, Calif. -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data from its Alzheimer’s development portfolio is being presented at the Alzheimer’s Association International Conference (AAIC) in Toronto, Canada (July 27-30). These data exemplify the comprehensive approach Roche is taking in addressing Alzheimer’s across the entire patient journey. Read More
Recent Posts
Kosovo Votes in Election Aimed at Breaking Political Deadlock
‘The past gives comfort’: Finding refuge on analog islands amid deepening digital seas
Senvest Capital Inc. Announces Death of Chief Executive Officer and Chairman of the Board
Brazilian judge puts coup plot convicts under house arrest after former police commander flees
US Lukoil Gas Station Owners Left in Limbo Over Russia Sanctions
What’s in the mix, and what’s at risk, for 2026: FP Video
In orbit: Canada’s satellite-to-cell offerings poised to grow after Rogers beta trial
Inside the failed green revolutions at BP and Shell
Zelenskiy Prepares for Trump Meeting as Russia Bombards Kyiv
Sure, the newspaper informed. But as it fades, those who used it for other things must adjust, too
